Clinical Trials Logo
  1. Home
  2. Dyslipidaemia
  3. NCT02523391

Bioequivalence Study of Capsule and Tablet Formulations of TA-8995

Dyslipidaemia Clinical Trial

Official title:
A Phase I, Randomised, Open-label Cross-over Bioequivalence Study of Capsule and Tablet Formulations of TA-8995 in Healthy Male Subjects

Clinical Trial Summary

The purpose of this study is to compare the pharmacokinetics of capsule and tablet formulations of TA-8995 in healthy male subjects aged 18 to 55 years.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02523391
Study type Interventional
Source Xention Ltd
Contact
Status Completed
Phase Phase 1
Start date July 2015
Completion date November 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT02230241 - CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II) N/A
Completed NCT04641299 - A Study of AZD8233 in Participants With Dyslipidemia Phase 2
Completed NCT01451918 - Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol Phase 2
Recruiting NCT01212328 - A Multi-site, Individually Randomized, Controlled Translation Trial of Integrated and Comprehensive Care Strategies to Reduce Cardiovascular Disease (CVD) Risk Among 1,120 Type 2 Diabetes Mellitus(T2DM) Patients in South Asia N/A
Completed NCT01221584 - Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia N/A
Completed NCT00654225 - Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS) Phase 3
Withdrawn NCT02557412 - Effect of Nasal CPAP on Lipid Profile in Patients With Dyslipidaemia and Sleep Apnea N/A
Completed NCT00653965 - Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP) Phase 3
Recruiting NCT04442334 - The European NAFLD Registry
Completed NCT00653744 - Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES) Phase 3
Completed NCT01632358 - Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients Phase 1
Completed NCT00474864 - Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia. Phase 2
Completed NCT00659321 - Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome Phase 3
Completed NCT01055977 - Statin Therapy Results in the Real World Practice in the Czech Republic N/A
Completed NCT00654602 - 48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety Phase 3
Recruiting NCT05979428 - A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the Blood Phase 1
Completed NCT02241759 - Study of the Electrocardiographic Effects of TA-8995 Phase 1
Completed NCT00158899 - GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol Phase 2